Prosecution Insights
Last updated: April 19, 2026

Cocrystal Pharma Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18015465 POLYCYCLIC CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR TREATING OR PREVENTING INFLUENZA KIFLE, BRUCK 1624 Non-Final OA Jan 10, 2023
17912749 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION PECKHAM, RICHARD GRANT 1627 Final Rejection Sep 19, 2022

Managing Cocrystal Pharma Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month